Before You Choose a PBM, do the Math
Cost is black & white Price alone isn’t. Your PBM must also control utilization or you’ll be seeing red.
Off Patent Medications & Drug Patent Expiration: Quarterly Drug Update
3 MIN READ
Managing pharmaceutical decisions in a claim can greatly impact the outcome of that claim, from recovery time to costs. Therefore, close monitoring of pharmacy changes and compliance updates is vital. In our previous quarterly update, we took a closer look at the utilization of generic drugs and 'me-too' medications.
Implications of Epidiolex FDA Approval on Workers' Compensation
4 MIN READ
In June 2018, the Federal Drug Administration (FDA) approved Epidiolex, the first plant-derived cannabinoid medicine in the United States. With several states already moving toward legalization of medical marijuana, this is a major step for the federal government.
How Differences in Claim Age and Population Affect Opioid Trends
1 MIN READ
Management of opioid therapy can be influenced by the types of drugs filled, differing patient populations, and the nature of the injury. Don’t miss our latest video blog where we will review some of the differences that point to the importance of early intervention and identification of long term risk.
Positive Compound Trends Continue in Work Comp
3 MIN READ
Utilization and costs associated with compound medications fell significantly for both managed and unmanaged claims in 2017.
Using Integrated Solutions to Help Improve The Workers Compensation Claim Process
9 MIN READ
From the moment an injury occurs, to the day an injured worker returns to work, the journey a workers’ compensation claim may take is complex, involving numerous parties and diverse jurisdictional requirements.
Overall Opioid Costs and Utilization is Down
1 MIN READ
Overall opioid cost and utilization continue to drop, due in part to market, societal, and regulatory influences, and the trend is expected to continue.
Stay Ahead in P&C
Get monthly insights from Enlyte experts to tackle your toughest claims challenges.